Host: Barnett Mennen, MD

Host Dr. Barry Mennen was joined by US Diabetes Experts to discuss Toujeo®, (insulin glargine injection) 300 units/mL, a long-acting human insulin analog indicated to improve glycemic control in adults with diabetes mellitus. Toujeo® is not recommended for treating diabetic ketoacidosis.

Dr. Barry Mennen welcomes:

• Dr. Timothy Gilbert, Clinical Endocrinologist at the Endocrinology Center of Southwest Louisiana, in Lake Charles, LA
• Advanced Practice Nurse and Certified Diabetes Educator - Deborah Hinnen, who is at the Memorial Hospital Diabetes Center part of the University of Colorado Health System, Colorado Springs, CO
• Dr. Udaya Kabadi, Adjunct Professor of Medicine at University of Iowa School of Medicine and an Endocrinologist involved in clinical research, Iowa City, IA
• Dr. Jeremy Pettus, Board-Certified Endocrinologist and Assistant Professor of Medicine at the University of California, San Diego, CA
• Jodi Strong, Doctorate Nurse Practitioner and Diabetes Educator, who is with the Ministry Medical Group in Stevens Point, Wisconsin
• Dr. Carol Wysham, Clinical Endocrinologist and Section Head of Rockwood Center for Diabetes and Endocrinology, Spokane, WA

Please click here for Full Prescribing Information for Toujeo®

Important Safety Information for Toujeo® (insulin glargine injection) 300 units/mL

Contraindications
Toujeo® ...